Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Iterum Therapeutics Announces NDA for Oral Sulopenem

americanpharmaceuticalreviewJanuary 29, 2021

Tag: Iterum , sulopenem , uUTI

PharmaSources Customer Service